AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2017

Jul 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2017-07-19

Reporting Person: Cantley Lewis Clayton Jr. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-19	Common stock	S	3000	$56.15	Disposed	86697	Direct
2017-07-19	Common stock	S	3000	$56.15	Disposed	86737	Indirect
2017-07-19	Common stock	S	500	$56.11	Disposed	86197	Direct
2017-07-19	Common stock	S	500	$56.11	Disposed	86237	Indirect
2017-07-20	Common stock	S	500	$57.12	Disposed	85697	Direct
2017-07-20	Common stock	S	500	$57.12	Disposed	85737	Indirect
2017-07-20	Common stock	S	500	$57.13	Disposed	85197	Direct
2017-07-20	Common stock	S	500	$57.13	Disposed	85237	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	25000	Indirect
Common stock	25000	Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.79 to $56.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse.

F4: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.85 to $56.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F7: Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.

F8: Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.